These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1535694)

  • 1. Milacemide and memory.
    Kadaba PK
    Neurology; 1992 Jul; 42(7):1434-5. PubMed ID: 1535694
    [No Abstract]   [Full Text] [Related]  

  • 2. Milacemide enhances memory storage and alleviates spontaneous forgetting in mice.
    Quartermain D; Nuygen T; Sheu J; Herting RL
    Pharmacol Biochem Behav; 1991 May; 39(1):31-5. PubMed ID: 1833781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milacemide, a glycine prodrug, on ethanol's antiseizure efficacy.
    Deutsch SI; Norris DO; O'Connor DA; Novitzki MR; Lukacs LG; Mastropaolo J
    Pharmacol Biochem Behav; 1992 Feb; 41(2):263-6. PubMed ID: 1533463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine-prodrug, milacemide, increases the seizure threshold due to hyperbaric oxygen; prevention by 1-deprenyl.
    Youdim MB; Kerem D; Duvdevani Y
    Eur J Pharmacol; 1988 Jun; 150(3):381-4. PubMed ID: 3138141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Labeling cerebral activity with 3H-deoxyglucose after milacemide administration in the rat].
    Van den Bosch de Aguilar P; Goemaere-Vanneste J
    Acta Neurol Belg; 1984; 84(1):21-5. PubMed ID: 6720246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of milacemide.
    van Dorsser W; Barris D; Cordi A; Roba J
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):239-49. PubMed ID: 6667068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells.
    Godfraind JM
    Br J Pharmacol; 1990 May; 100(1):119-25. PubMed ID: 2196964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of milacemide on item and source memory.
    Schwartz BL; Hashtroudi S; Herting RL; Deutsch SI
    Clin Neuropharmacol; 1992 Apr; 15(2):114-9. PubMed ID: 1591737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of gamma-aminobutyric acid in the mechanism of action of anticonvulsant drugs].
    Chmielewska B
    Neurol Neurochir Pol; 2000; 34(1):133-43. PubMed ID: 10849911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of action of gabapentin and pregabalin.
    Sills GJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):108-13. PubMed ID: 16376147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: antagonism by NMDA receptor blockers.
    Bowery NG; Bagetta G; Nisticó G; Britton P; Whitton P
    Epilepsy Res Suppl; 1992; 9():249-56. PubMed ID: 1363043
    [No Abstract]   [Full Text] [Related]  

  • 13. An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy.
    Rosse RB; Schwartz BL; Leighton MP; Davis RE; Deutsch SI
    Clin Neuropharmacol; 1990 Aug; 13(4):348-54. PubMed ID: 2145067
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycine prodrug facilitates memory retrieval in humans.
    Schwartz BL; Hashtroudi S; Herting RL; Handerson H; Deutsch SI
    Neurology; 1991 Sep; 41(9):1341-3. PubMed ID: 1653913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):317-30. PubMed ID: 6431211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and milacemide.
    Youdim MB
    Mov Disord; 1994 Sep; 9(5):585-6. PubMed ID: 7990857
    [No Abstract]   [Full Text] [Related]  

  • 17. Milacemide therapy for Parkinson's disease.
    Giuffra ME; Sethy VH; Davis TL; Mouradian MM; Chase TN
    Mov Disord; 1993; 8(1):47-50. PubMed ID: 8380487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
    Sofia RD
    Ann Neurol; 1994 Oct; 36(4):677-8. PubMed ID: 7944305
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurobiology of neuropathic pain: mode of action of anticonvulsants.
    Dickenson AH; Matthews EA; Suzuki R
    Eur J Pain; 2002; 6 Suppl A():51-60. PubMed ID: 11888242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.